Search research articles
Contact Us
Filters
Showing results (81-90 of 145) with videos related to
Page
of 15
Sort By:
Journal of Neuro-Oncology
|
December 22, 2017
Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma
Deborah R Smith, Cheng-Chia Wu, Heva J Saadatmand, et al.
Neurosurgery
|
October 7, 2015
Timing of Adjuvant Radiotherapy in Glioblastoma Patients: A Single-Institution Experience With More Than 400 Patients
Tony J C Wang, Ashish Jani, Juan P Estrada, et al.
Neuro-Oncology
|
April 26, 2015
Does lung cancer mutation status and targeted therapy predict for outcomes and local control in the setting of brain metastases treated with radiation?
Tony J C Wang, Shumaila Saad, Yasir H Qureshi, et al.
Neuro-Oncology
|
January 8, 2023
Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival
Benjamin M Ellingson, Patrick Y Wen, Susan M Chang, et al.
Neuro-Oncology
|
August 8, 2014
Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma
Thomas J Kaley, Patrick Wen, David Schiff, et al.
Journal of Neuro-Oncology
|
November 29, 2019
A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma
Martin van den Bent, Analia Azaro, Filip De Vos, et al.
Journal of Neuro-Oncology
|
November 25, 2017
Local control and overall survival for adjuvant stereotactic radiosurgery in patients with residual or recurrent disease
Tavish Nanda, Andrew Yaeh, Cheng-Chia Wu, et al.
Neuro-Oncology
|
December 18, 2012
Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma
Antonio Omuro, Timothy A Chan, Lauren E Abrey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2019
Comparison of Biomarker Assays for <i>EGFR</i>: Implications for Precision Medicine in Patients with Glioblastoma
Andrew B Lassman, Lisa Roberts-Rapp, Irina Sokolova, et al.
Neuro-Oncology
|
January 1, 2017
Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma
David A Reardon, Andrew B Lassman, Martin van den Bent, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 145) with videos related to
Sort By:
Page
of 15
Journal of Neuro-Oncology
|
December 22, 2017
Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma
Deborah R Smith, Cheng-Chia Wu, Heva J Saadatmand, et al.
Neurosurgery
|
October 7, 2015
Timing of Adjuvant Radiotherapy in Glioblastoma Patients: A Single-Institution Experience With More Than 400 Patients
Tony J C Wang, Ashish Jani, Juan P Estrada, et al.
Neuro-Oncology
|
April 26, 2015
Does lung cancer mutation status and targeted therapy predict for outcomes and local control in the setting of brain metastases treated with radiation?
Tony J C Wang, Shumaila Saad, Yasir H Qureshi, et al.
Neuro-Oncology
|
January 8, 2023
Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival
Benjamin M Ellingson, Patrick Y Wen, Susan M Chang, et al.
Neuro-Oncology
|
August 8, 2014
Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma
Thomas J Kaley, Patrick Wen, David Schiff, et al.
Journal of Neuro-Oncology
|
November 29, 2019
A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma
Martin van den Bent, Analia Azaro, Filip De Vos, et al.
Journal of Neuro-Oncology
|
November 25, 2017
Local control and overall survival for adjuvant stereotactic radiosurgery in patients with residual or recurrent disease
Tavish Nanda, Andrew Yaeh, Cheng-Chia Wu, et al.
Neuro-Oncology
|
December 18, 2012
Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma
Antonio Omuro, Timothy A Chan, Lauren E Abrey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2019
Comparison of Biomarker Assays for <i>EGFR</i>: Implications for Precision Medicine in Patients with Glioblastoma
Andrew B Lassman, Lisa Roberts-Rapp, Irina Sokolova, et al.
Neuro-Oncology
|
January 1, 2017
Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma
David A Reardon, Andrew B Lassman, Martin van den Bent, et al.
Page
of 15